| A Molecular Link between the Active Component of Marijuana and Alzheimer's Disease Pathology | Eubanks et al. |
| Molecular Pharmaceutics ASAP Article 10.1021/mp060066m |
9/8/06 |
| |
| A Report of the National Commission on Ganja to the Prime Minister of Jamaica | Prof. Barry Chevannes, Chairman, et al |
| National Commission on Ganja, Jamaica |
Aug 7, 2001 |
| |
| Acute effects of smoked marijuana and oral d-9-thc on specific airway conductance in asthmatic subjects | Tashkin, Shapiro, and Frank |
| American Review of Respiratory Disease, Volume 109, p. 420-428 |
1974 |
| |
| An endocannabinoid mechanism for stress-induced analgesia | Hohmann et al. |
| Nature vol 435 p1108-1112 |
23/06/05 |
| |
| An open-label pilot study of cannabis-based extracts for bladder dysfunction in advanced multiple sclerosis. | Brady et al. |
| Multiple Sclerosis 10(4):425-33 |
August 2004 |
| |
| Analgesic and anti-inflammatory activity of constituents of Cannabis Sativa L. | E.A. Formukong, A.T. Evans, and F.J. Evans |
| Inflammation, Vol 12, No. 4 |
1988 |
| |
| Anti-Tumor Effects | GW Pharmaceuticals |
|
|
| |
| Antiemetic effect of Delta-9-Tetrahydrocannabinol in patients receiving Cancer Chemotherapy | Sallan, Stephen E., Norman E. Zinberg, and Emil Frei. |
| New England Journal of Medicine Vol. 293(16) 795-797. |
1975 |
| |
| Antineoplastic activity of cannabinoids | Munson, Harris, Friedman, Dewey and Carchman |
| Journal of the National Cancer Institute v55 no. 3 |
September 1975 |
| |
| Anxiety with Depression Research Review | Edward Glick |
| Oregon Medical Marijuana Act Debilitating Medical Conditions Advisory Panel |
27/03/00 |
| |
| Are cannabinoids an effective and safe treatment option in the management of pain? A qualitative systematic re | Campbell et al. |
| British Medical Journal 323(7303):13-6 |
07/07/01 |
| |
| BMA report calls for change in law and development of new cannabis-based medicines | |
| British Medical Association |
18/11/97 |
| |
| Body's 'cannabis' could hold blood pressure key | |
| BBC Online |
Dec 29, 1998 |
| |
| Brain chemicals mimic marijuana | Johnathon S. Choi |
| Reuters |
Aug 1997 |
| |
| Cannabidiol and D9-tetrahydrocannabinol are neuroprotective antioxidants | Hampson, Grimaldi, Axelrod and Wink |
| Proceedings of the National Academy of Sciences Vol. 95, pp. 8268–8273 |
July 1998 |
| |
| Cannabidiol: The Wonder Drug of the 21st Century? | |
|
|
| |
| Cannabinoids and Brain Injury | Mechoulam, Panikashvili, Shohami |
| TRENDS in Molecular Medicine Vol.8 No.2 |
February 2002 |
| |
| Cannabinoids block release of serotonin from platelets induced by plasma from migraine patients | Volfe Z., Dvilansky A., Nathan I. |
| Int J Clin Pharm. Res V (4) 243-246 |
1985 |
| |
| Cannabinoids control spasticity and tremor in a multiple sclerosis model | David Baker, et al. |
| Nature |
20 Jan 2000 |
| |
| Cannabinoids for control of chemotherapy induced nausea and vomiting: quantitative systematic review | Tramer et al. |
| British Medical Journal 2001;323:1–8 |
7/7/01 |
| |
| Cannabinoids for treatment of spasticity and other symptoms related to multiple sclerosis (CAMS study) | Zajicek et al. |
| Lancet 2003; 362: 1517–26 |
2003 |
| |
| Cannabinoids in bipolar affective disorder: a review and discussion of their therapeutic potential | Ashton et al. |
| Journal of Psychopharmacology, Vol. 19, No. 3, 293-300 |
2005 |
| |
| Cannabinoids on the Brain | Andrew J. Irving, Mark G. Rae, Angela A. Coutts |
| TheScientificWorldJOURNAL (2002) 2, 632-648 |
2002 |
| |
| Cannabinoids promote embryonic and adult hippocampus neurogenesis and produce anxiolytic- and antidepressant-like effects | Jiang et al. |
| Journal of Clinical Investigation [Electronic publication ahead of print] |
13/10/05 |
| |
| Cannabinoids: Potential Anticancer Agents | Manuel Guzman |
| Nature Reviews |
1 Oct 2003 |
| |
| Cannabis - Government Response | The House of Lords, Science and Technology Committee |
|
4 March 1999 |
| |
| Cannabis and schizophrenia: results of a follow-up study | Dieter Caspari |
| European Archives of Psychiatry and Clinical Neuroscience 249 :45–49 |
1999 |
| |
| Cannabis and the brain | Leslie Iversen |
| Brain vol 126 p1252-1270. |
2003 |
| |
| Cannabis antagonists: a new era of social psychopharmacology? | Nutt, D. |
| Journal of Psychopharmacology 19(1):3-4. |
January 2005 |
| |
| Cannabis for migraine treatment: The once and future prescription? An historical and scientific review | Russo E. |
| Pain 1998;76(1-2):3-8. |
1998 |
| |
| Cannabis treatments in Obstetrics and Gynecology: A historical review | Ethan Russo |
| Journal of Cannabis Therapeutics Vol. 2, No. 3/4, p5-35 |
2002 |
| |
| Cannabis, cannabinoids and reproduction | Boram Park, John McPartland and Michelle Glass |
| Prostaglandins, Leukotrienes and Essential Fatty Acids 70 189–197 |
2004 |
| |
| Cannabis: Medical reality versus authoritarian brutality | Ian Williams Goddard |
|
1996 |
| |
| Cannabis: The Scientific And Medical Evidence | The House of Lords, Science and Technology Committee |
|
4 Nov 1998 |
| |
| Clinical Studies and Case Reports | |
| International Association for Cannabis as Medicine |
|
| |
| Control by the endogenous cannabinoid system of ras oncogene-dependent tumor growth | Maurizio Bifulco et al. |
| Federation of American Societies for Experimental Biology Journal |
29/10/01 |
| |
| Counterblast to the I.O.M. | Peter Webster |
| International Journal of Drug Policy |
1999 |
| |
| Decreased depression in marijuana users | Denson and Earleywine |
| Addictive Behaviors (electronic publication ahead of print) |
17/06/05 |
| |
| Delta-9 tetrahydrocannabinol (THC) inhibits lytic replication of gamma oncogenic herpesviruses in vitro | Medveczky, Sherwood, Klein, Friedman, and Medveczky |
| BMC Medicine 2004, 2:34 |
15/09/04 |
| |
| Delta-9-tetrahydrocannabinol effects in schizophrenia: implications for cognition, psychosis, and addiction | D'Souza et al. |
| Biological Psychiatry 15;57(6):594-608 |
March 2005 |
| |
| Delta-9-Tetrahydrocannibinol as an antiemetic in cancer patients receiving high-dose Methotrexate | Chang et al. |
| Annals of Internal Medicine 91: 819-824 |
December 1979 |
| |
| Differential cannabinoid receptor signaling by anandamide directs blastocyst activation for implantation | Wang, Matsumoto, Guo, Paria, Roberts, Dey |
| Proceedings of the National Academy of Sciences vol 100, no 25, 14914-14919 |
9/12/03 |
| |
| Differential effects of medical marijuana based on strain and route of administration:A three-year observation | Valerie Leveroni Corral |
| Wo/Men's Alliance for Medical Marijuana |
2001 |
| |
| Do cannabis-based medicinal extracts have general or specific effects on symptoms in multiple sclerosis? | Wade et al. |
| Multiple Sclerosis 10(4):434-441 |
August 2004 |
| |
| Does the cannabinoid dronabinol reduce central pain in multiple sclerosis? | Svendsen, Jensen, Bach |
| British Medical Journal 329 (7460): 253 |
31/07/04 |
| |
| Effect of marihuana on intraocular and blood pressure in glaucoma | Merritt, Crawford, Alexander, Anduze and Gelbart |
| Ophthalmology Vol. 87, No. 3, pp. 222-228 |
March 1980 |
| |
| Effects of cannabidiol on schizophrenia-like symptoms in people who use cannabis | Morgan and Curran |
| The British Journal of Psychiatry (2008) 192, 306–307 |
2008 |
| |
| Effects of cannabis and psychosis vulnerability in daily life: an experience sampling test study | Verdoux et al. |
| Psychological Medicine, 2003, 33, 23-32. |
2003 |
| |
| Effects of Smoked Marijuana in Experimentally Induced Asthma | Tashkin, Shapiro, Lee and Harper |
| American Review of Respiratory Disease, Vol. 112 |
1975 |
| |
| Efficacy of two cannabis based medicinal extracts for relief of central neuropathic pain from brachial plexus | Berman, Symonds, Birch |
| Pain 112 (2004) 299–306 |
2004 |
| |
| Efficacy, safety and tolerability of an...cannabis extract in the treatment of spasticity in...MS | Vaney et al. |
| Multiple Sclerosis 10(4):417-24 |
August 2004 |
| |
| Emerging properties of cannabinoid medicines in management of multiple sclerosis. | Pryce G, Baker D. |
| Trends in Neurosciences 28(5):272-6 |
May 2005 |
| |
| Endocannabinoid metabolism in human glioblastomas and meningiomas compared to human non-tumour brain tissue | Petersen et al. |
| Journal of Neurochemistry 93(2):299-309 |
April 2005 |
| |
| Endocrine Effects of Marijuana | Todd T. Brown, MD, and Adrian S. Dobs, MD, MHS |
| Journal of Clinical Pharmacology, 2002;42:90S-96S |
2002 |
| |
| Excerpt from the Merck Manual | Robert Berkow |
| Merck Manual of Diagnosis and Therapy, 15th edition |
1987 |
| |
| Familial Predisposition for Psychiatric Disorder - Comparison of Subjects Treated for Cannabis-Induced Psychosis and Schizophrenia | Arendt, Mortensen, Rosenberg, Pedersen, Waltoft |
| Arch Gen Psychiatry. 2008;65(11):1269-1274 |
2008 |
| |
| Hemp for headache: An in-depth historical and scientific review of cannabis in migraine treatment | Russo E. |
| Journal of Cannabis Therapeutics 2001;1(2):21-92. |
2001 |
| |
| HU308 - A specific agonist for CB2, a peripheral cannabinoid receptor | L. Hanus et al. |
| Proceedings of the National Academy of Sciences 96:25, 14228-14233 |
07/12/99 |
| |
| Inhibition of Glioma Growth in Vivo by Selective Activation of the CB2 cannabinoid receptor | Cristina Sanchez et al. |
| Cancer Research 61, 5784-5789 |
01/08/01 |
| |
| Inhibition of skin tumor growth and angiogenesis in vivo by activation of cannabinoid receptors | M. Llanos Casanova et al. |
| Journal of Clinical Investigation 111:43-50 |
2003 |
| |
| Initial experiences with medicinal extracts of cannabis for chronic pain: Results from 34 'N of 1' studies | Notcutt, Price, Miller, Newport, Phillips, Simmons and Sansom |
| Anaesthesia, 2004, 59, pp440–452 |
2004 |
| |
| Is cannabis an anti-antipsychotic? The experience in psychiatric intensive care | Isaac M, Isaac M, Holloway F |
| Human Psychopharmacology 2005 Apr;20(3):207-10. |
April 2005 |
| |
| Low dose oral cannabinoid therapy reduces progression of atherosclerosis in mice | Steffens et al. |
| Nature 434, 782 - 786 |
07/04/05 |
| |
| Marijauna and the brain part 2: The tolerance factor | Jon Gettman |
| High Times |
July 1995 |
| |
| Marijauna and the human brain | Jon Gettman |
| High Times |
March 1995 |
| |
| Marijuana - a missed market opportunity? | Lisa Nainggolan |
| Scrip World Pharmaceutical News |
December 1997 |
| |
| Marijuana and medicine: Assessing the science base | Janet E. Joy, Stanley J. Watson, Jr., and John A. Benson, Jr., Editors |
| US Institute of Medicine (IOM) |
1999 |
| |
| Marijuana as medicine - A recent history (1976-1996) with recommendations | Robert C. Randall and Alice M. O'Leary |
|
1996 |
| |
| Marijuana as medicine: A plea for reconsideration | Lester Grinspoon and James B. Bakalar |
| Journal of the American Medical Association - Vol. 273, No. 23 1875 |
21/06/95 |
| |
| Marijuana Effects on the Endocrine and Reproductive Systems | Braude and Ludford |
| NIDA Research Monograph 44 |
1984 |
| |
| Medical cannabis fact sheets | |
| The Alliance for Cannabis Therapeutics |
|
| |
| Medical Marijuana | Jane B. Marmor |
| Western Journal of Medicine 1998; 168: 540-543 |
1998 |
| |
| Medicinal cannabis and derivatives | |
| European Monitoring Centre for Drugs and Drugs Addiction (EMCDDA) |
May 2002 |
| |
| Mesenteric Vasodilation Mediated by Endothelial Anandamide Receptors | Jens A. Wagner, Karoly Varga, Zoltan Jarai, George Kunos |
| Hypertension 33(1 Pt 2):429-34. |
January 1999 |
| |
| Neurons on cannabinoids: dead or alive? | Manuel Guzman |
| British Journal of Pharmacology 140:439-440 |
2003 |
| |
| On the pharmaceuticalization of marijuana | Lester Grinspoon |
| International Journal of Drug Policy Vol 12, 5-6, pp 377-383 |
01/11/01 |
| |
| Preliminary assessment of the efficacy, tolerability and safety of a cannabis-based medicine (Sativex) in the treatment of pain caused by rheumatoid arthritis | Blake et al. |
| Rheumatology Advance Access |
9/11/05 |
| |
| Preliminary study to determine whether whole-plant cannabis extracts improve intractable neurogenic symptoms | Derick T Wade, Philip Robson, Heather House, Petra Makela and Julia Aram |
| Clinical Rehabilitation 2003; 17: 21–29 |
2003 |
| |
| Product monograph for Sativex | |
| GW Pharma Ltd. |
13/04/05 |
| |
| Proven: Cannabis is safe medicine | Ian Williams Goddard |
|
1996 |
| |
| Psychiatric aspects of marihuana intoxication | Samuel Allentuck and Karl Bowman |
| American Journal of Psychiatry |
September 1942 |
| |
| Self-change: A pathway to cannabis abuse resolution | Ellingstad et al. |
| Addictive Behaviors (electronic publication ahead of print) |
18/06/05 |
| |
| Some cannabis research from 1975 - present | |
| Medline |
1998 |
| |
| Study gauges secondhand smoke toll | |
| San Jose Mercury News |
24/10/97 |
| |
| Targeting CB2 cannabinoid receptors as a novel therapy to treat malignant lymphoblastic disease | Robert J. McKallip et al |
| Blood, Vol. 100, No. 2, pp. 627-634 |
15 July 2002 |
| |
| Tetrahydrocannabinol-induced neurotoxicity depends on CB1 receptor-mediated c-Jun N-terminal kinase activation | Eric J Downer, Marie P Fogarty and Veronica A Campbell |
| British Journal of Pharmacology 140:547-557 |
2003 |
| |
| The cannabinoids in MS study – final results from 12 months follow-up | J. Zajicek |
| Multiple Sclerosis 10 (2004) (Suppl), p. S115. |
September 2004 |
| |
| The endogenous cannabinoid anandamide inhibits human breast cancer cell proliferation | De Petrocellis, Melck, Palmisano, Bisogno, Laezza, Bifulco, Di Marzo |
| Proceedings of the National Academy of Sciences 95: 8375-8380 |
July 1998 |
| |
| The endogenous cannabinoid system protects against colonic inflammation | Massa F, et al |
| The Journal of Clinical Investigation 113 (8): 1202–1209 |
15/04/04 |
| |
| The Medical Marijuana Issue Among PWAs: Reports of Therapeutic Use and Attitudes Toward Legal Reform | Ben Wesner |
| Working Paper Series, University of Hawaii at Minoa |
June 1996 |
| |
| The nonpsychoactive component of marijuana cannabidiol modulates chemotaxis and IL-10 and IL-12 production... | Sacerdote P, et al |
| Journal of Neuroimmunology 159(1-2):97-105 |
2005 |
| |
| The therapeutic potential of cannabis | Baker, Pryce, Giovannoni, and Thompson |
| The Lancet Neurology Vol 2 p291-298 |
May 2003 |
| |
| The therapeutic value of cannabinoids in MS: real or imaginary? | Killestein and Polman |
| Multiple Sclerosis 10(4):339-40. |
August 2004 |
| |
| The Use of Cannabis as a Mood Stabilizer in Bipolar Disorder | Lester Grinspoon, M.D. & James B. Bakalar |
| Journal of Psychoactive Drugs |
Apr/Jun 1998 |
| |
| Therapeutic aspects of cannabis and cannabinoids | Philip Robson |
| The British Journal of Psychiatry vol. 178 pp. 107-115 |
February 2001 |
| |
| Therapeutic Potential and Medical Uses of Marijuana | Tod Mikuriya |
| Journal of Psychoactive Drugs 14: 239-241 |
1982 |
| |
| Therapeutic Uses Of Cannabis | The House of Lords, Science and Technology Committee |
|
14 March 2001 |
| |
| Use of cannabinoids in MS: is it evidence based? | C. Vaney, Berner Klinik |
| Multiple Sclerosis 2004 10 (suppl 2): 115 |
2004 |
| |
